Biondvax Pharma ADR (BVXV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BVXV | AMGN | VRTX | BMY | GILD |
| Company | Biondvax Pharma ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.3200 | 316.16 | 483.00 | 55.14 | 89.64 |
| High | 1.3700 | 319.52 | 503.21 | 56.24 | 90.39 |
| Low | 1.3200 | 313.02 | 474.00 | 54.72 | 89.01 |
| Last | 1.3600 | 318.71 | 498.67 | 56.12 | 90.26 |
| Change | +0.0500 | +1.80 | +25.87 | +0.67 | +0.42 |
| % Change | +3.82% | +0.57% | +5.47% | +1.21% | +0.47% |
| Volume | 23,000 | 591,737 | 942,984 | 4,247,379 | 1,807,523 |
| 20-Day Average Volume | 12,760 | 1,675,626 | 1,029,450 | 8,445,726 | 5,042,505 |
| Previous Close | 1.3100 | 316.91 | 472.80 | 55.45 | 89.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3207 | 319.65 | 478.84 | 53.25 | 87.52 |
| 20-Day Raw Stochastic | 78.57% | 39.20% | 97.91% | 99.29% | 93.12% |
| 20-Day Relative Strength | 49.42% | 46.63% | 60.32% | 64.66% | 69.91% |
| Weighted Alpha | -64.90 | +16.06 | +32.22 | +19.01 | +27.72 |
| Today's Opinion | 88% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 24% Buy | 8% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 08/29/23 | +0.60% since 10/29/24 | +5.97% since 10/29/24 | +7.06% since 10/29/24 | +2.48% since 10/29/24 |
| Low | 1.3000 on 09/01/23 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 52.29 on 10/30/24 | 87.48 on 10/30/24 |
| High | 1.3700 on 09/06/23 | 323.40 on 10/31/24 | 499.36 on 11/05/24 | 56.24 on 11/05/24 | 90.71 on 11/04/24 |
| 1-Month | |||||
| %Chg | -1.45% since 08/04/23 | -0.55% since 10/04/24 | +9.48% since 10/04/24 | +4.16% since 10/04/24 | +6.70% since 10/04/24 |
| Low | 1.2500 on 08/22/23 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 1.3900 on 08/28/23 | 329.17 on 10/11/24 | 499.36 on 11/05/24 | 56.24 on 11/05/24 | 90.71 on 11/04/24 |
| 3-Month | |||||
| %Chg | -5.00% since 06/06/23 | -2.25% since 08/05/24 | +4.52% since 08/05/24 | +18.10% since 08/05/24 | +20.62% since 08/05/24 |
| Low | 1.2500 on 08/22/23 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 1.8703 on 07/12/23 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 56.24 on 11/05/24 | 90.71 on 11/04/24 |
| 6-Month | |||||
| %Chg | -40.09% since 03/06/23 | +2.12% since 05/03/24 | +24.28% since 05/03/24 | +27.77% since 05/03/24 | +39.33% since 05/03/24 |
| Low | 1.2500 on 08/22/23 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 2.4400 on 04/17/23 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.24 on 11/05/24 | 90.71 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,540 | 170,284,928 | 122,030,624 | 112,462,416 | 111,850,072 |
| Shares Outstanding, K | 1,868 | 537,329 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -5,800,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -3,760,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | 2.37 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.11 on 08/11/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 08/24/23 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 0.00 | 46.43 | 19.04 |